Shanghai Hile Bio-Technology Co., Ltd. (603718.SS)
CNY 7.75
(-0.64%)
CNY 7.75
(-0.64%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 55.17 Million CNY | -63.84% |
| 2022 | 152.56 Million CNY | 166.53% |
| 2021 | 57.24 Million CNY | 359.17% |
| 2020 | 12.46 Million CNY | -57.87% |
| 2019 | 29.58 Million CNY | 33.41% |
| 2018 | 22.17 Million CNY | -78.84% |
| 2017 | 104.83 Million CNY | 43.39% |
| 2016 | 73.11 Million CNY | -33.3% |
| 2015 | 109.61 Million CNY | 4.66% |
| 2014 | 104.73 Million CNY | -20.77% |
| 2013 | 132.18 Million CNY | 4.22% |
| 2012 | 126.83 Million CNY | 8.66% |
| 2011 | 116.72 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -5.51 Million CNY | 74.21% |
| 2024 Q3 | -11.54 Million CNY | 9.25% |
| 2024 Q2 | -12.72 Million CNY | -130.79% |
| 2023 Q1 | 14.64 Million CNY | -33.5% |
| 2023 FY | 55.17 Million CNY | -63.84% |
| 2023 Q2 | 33.99 Million CNY | 132.21% |
| 2023 Q4 | -21.37 Million CNY | -205.59% |
| 2023 Q3 | -6.99 Million CNY | -120.58% |
| 2022 Q3 | 14.42 Million CNY | -34.01% |
| 2022 FY | 152.56 Million CNY | 166.53% |
| 2022 Q4 | 22.01 Million CNY | 52.58% |
| 2022 Q1 | 11.61 Million CNY | -16.73% |
| 2022 Q2 | 21.86 Million CNY | 88.29% |
| 2021 FY | 57.24 Million CNY | 359.17% |
| 2021 Q1 | 13.42 Million CNY | 293.32% |
| 2021 Q2 | 15.28 Million CNY | 13.87% |
| 2021 Q3 | 14.58 Million CNY | -4.57% |
| 2021 Q4 | 13.94 Million CNY | -4.39% |
| 2020 Q4 | -6.94 Million CNY | -264.86% |
| 2020 Q1 | 3.4 Million CNY | 415.54% |
| 2020 Q3 | -1.9 Million CNY | 88.23% |
| 2020 Q2 | -16.16 Million CNY | -575.02% |
| 2020 FY | 12.46 Million CNY | -57.87% |
| 2019 Q1 | 957.54 Thousand CNY | 107.76% |
| 2019 FY | 29.58 Million CNY | 33.41% |
| 2019 Q2 | 5.26 Million CNY | 449.54% |
| 2019 Q4 | -1.07 Million CNY | -157.34% |
| 2019 Q3 | 1.88 Million CNY | -64.26% |
| 2018 Q1 | 19.46 Million CNY | -43.63% |
| 2018 FY | 22.17 Million CNY | -78.84% |
| 2018 Q4 | -12.33 Million CNY | -226.45% |
| 2018 Q3 | 9.75 Million CNY | 84.19% |
| 2018 Q2 | 5.29 Million CNY | -72.79% |
| 2017 Q1 | 21.21 Million CNY | 379.71% |
| 2017 FY | 104.83 Million CNY | 43.39% |
| 2017 Q4 | 34.52 Million CNY | 20.52% |
| 2017 Q3 | 28.64 Million CNY | 40.06% |
| 2017 Q2 | 20.45 Million CNY | -3.59% |
| 2016 Q2 | 21.14 Million CNY | -31.9% |
| 2016 FY | 73.11 Million CNY | -33.3% |
| 2016 Q3 | 16.49 Million CNY | -22.0% |
| 2016 Q1 | 31.05 Million CNY | 24.68% |
| 2016 Q4 | 4.42 Million CNY | -73.19% |
| 2015 Q1 | 32.51 Million CNY | 152.9% |
| 2015 FY | 109.61 Million CNY | 4.66% |
| 2015 Q4 | 24.9 Million CNY | -0.61% |
| 2015 Q3 | 25.05 Million CNY | -7.66% |
| 2015 Q2 | 27.13 Million CNY | -16.55% |
| 2014 FY | 104.73 Million CNY | -20.77% |
| 2014 Q3 | 30 Million CNY | 20.31% |
| 2014 Q1 | 36.92 Million CNY | 0.0% |
| 2014 Q2 | 24.94 Million CNY | -32.46% |
| 2014 Q4 | 12.85 Million CNY | -57.15% |
| 2013 FY | 132.18 Million CNY | 4.22% |
| 2012 FY | 126.83 Million CNY | 8.66% |
| 2011 FY | 116.72 Million CNY | 0.0% |